E. S. Gragoudas
About
In The Last Decade
E. S. Gragoudas
41 papers receiving 747 citations
Peers
Comparison fields: 5 of 77
- Ophthalmology 608
- Radiology, Nuclear Medicine and Imaging 269
- Molecular Biology 200
- Pulmonary and Respiratory Medicine 121
- Oncology 66
Countries citing papers authored by E. S. Gragoudas
This map shows the geographic impact of E. S. Gragoudas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. S. Gragoudas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. S. Gragoudas more than expected).
Fields of papers citing papers by E. S. Gragoudas
This network shows the impact of papers produced by E. S. Gragoudas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. S. Gragoudas. The network helps show where E. S. Gragoudas may publish in the future.
Co-authorship network of co-authors of E. S. Gragoudas
This figure shows the co-authorship network connecting the top 25 collaborators of E. S. Gragoudas. A scholar is included among the top collaborators of E. S. Gragoudas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. S. Gragoudas. E. S. Gragoudas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Identification of Necroptosis as a Mechanism of Photoreceptor Damage After Retinal Detachment and Nec-1 as a Potential Treatment | 1 |
| 2 | Effects of ApoE Deficiency, Aging and High Fat Diet on Laser-Induced Choroidal Neovascularization and Bruch's Membrane-RPE Interface Morphology | 8 |
| 3 | In vivo Imaging of Endothelial Injury in the Choriocapillaris During Endotoxin-Induced Uveitis | 1 |
| 4 | Increased Laser–Induced Choroidal Neovascularization in Mice Lacking Collagen XVIII/Endostatin | 1 |
| 5 | VEGF Inhibition Study in Ocular Neovascularization–1 (VISION–1): Efficacy Results From Phase II/III MacugenTM (Pegaptanib Sodium) Clinical Trials | 4 |
| 6 | Chlamydia pneumoniae is identified in human choroidal neovascular membranes secondary to age–related macular degeneration and induces vascular endothelial growth factor in vitro | 2 |
| 7 | Enhanced Photodynamic Therapy using Angiostatin with Verteporfin PDT in a Laser-injury Rat Model | 1 |
| 8 | Safety and Efficacy of Intravitreal Injection of rhuFab VEGF in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization | 5 |
| 9 | Modified Verteporfin Photodynamic Therapy (PDT), PDT Combined With Angiostatin In Vitro and In Vivo | 1 |
| 10 | Selective Targeting of Verteporfin to Choroidal Neovascularization Mediated by a Homing Peptide to VEGF-R2 | 1 |
| 11 | MRI of Blood Volume With MS 325 in Experimental Choroidal Melanoma | 2 |
| 12 | Comparison of fluorescein angiography and indocyanine green angiography after photodynamic therapy for choroidal neovascularization | 1 |
| 13 | Preliminary results of photodynamic therapy for choroidal neovascularization in pathologic myopia. ocular histoplasmosis syndrome and idiopathic causes within a phase i/ii study | 8 |
| 14 | Photodynamic therapy of subfoveal choroidal neovascularization using benzoporphyrin derivative: First results of a multi-center trial | 2 |
| 15 | 19 | |
| 16 | INHIBITION OF VEGF PREVENTS OCULAR NEOVASCULARIZATION IN A MONKEY MODEL | 5 |
| 17 | Photodynamic therapy of pigmented choroidal melanomas. | 29 |
| 18 | Photodynamic therapy of experimental choroidal neovascularization using liposomal benzoporphyrin derivative monoacid Refinement of dosimetry | 2 |
| 19 | Increased efficacy of radiation therapy by use of proton beam. | 36 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.